In the trial data published so far, retatrutide has produced larger average weight loss than Mounjaro, with 28.7% at 68 weeks in TRIUMPH-4 versus 22.5% at 72 weeks in SURMOUNT-1
For patients seeking more affordable access to approved weight loss medications, exploring cash-pay options through reliable pharmacy services can provide significant savings
With such a large sample size, scientists may be able to learn more about the different types of obesity, through the prism of how people respond to the medicines both while taking them, and after their treatment ends
GLP-1s can usually help people lose about 15 to 20 percent of their body weight, which translates to about 35 to 50 pounds, depending on a persons starting weight, says Dr
Traditional gastric bypass patients typically lose 25-30% of their body weight, putting this injectable compound in the same effectiveness category as major surgical interventions
SeekPeptides has compiled every relevant study, clinical data point, and practical recommendation into a single guide
